Chugai Pharmaceutical Co., Ltd Stock price

Equities

4519

JP3519400000

Pharmaceuticals

Market Closed - Japan Exchange 02:00:00 2024-03-28 am EDT 5-day change 1st Jan Change
5,766 JPY -2.72% Intraday chart for Chugai Pharmaceutical Co., Ltd -4.85% +7.94%
Sales 2023 1,111B 7.34B Sales 2024 * 1,092B 7.22B Capitalization 9,752B 64.42B
Net income 2023 325B 2.15B Net income 2024 * 344B 2.27B EV / Sales 2023 7.24 x
Net cash position 2023 739B 4.88B Net cash position 2024 * 802B 5.3B EV / Sales 2024 * 8.19 x
P/E ratio 2023
27 x
P/E ratio 2024 *
28.4 x
Employees 7,771
Yield 2023
1.5%
Yield 2024 *
1.43%
Free-Float 38.08%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Chugai Pharmaceutical Co., Ltd

1 day-2.72%
1 week-5.48%
Current month-3.90%
1 month-3.21%
3 months+7.06%
6 months+24.89%
Current year+7.94%
More quotes
1 week
5 720.00
Extreme 5720
5 985.00
1 month
5 720.00
Extreme 5720
6 697.00
Current year
5 043.00
Extreme 5043
6 697.00
1 year
3 203.00
Extreme 3203
6 697.00
3 years
3 191.00
Extreme 3191
6 697.00
5 years
2 240.00
Extreme 2240
6 697.00
10 years
801.67
Extreme 801.6667
6 697.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 87-03-31
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 79 15-02-28
Director/Board Member 66 84-03-31
Director/Board Member 65 19-02-28
More insiders
Date Price Change Volume
24-03-28 5,766 -2.72% 2 396 900
24-03-27 5,927 -0.20% 2,716,800
24-03-26 5,939 +1.52% 2,473,700
24-03-25 5,850 -0.53% 2,178,700
24-03-22 5,881 -3.59% 3,559,200

Delayed Quote Japan Exchange, March 28, 2024 at 02:00 am EDT

More quotes
Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%). Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
5,927 JPY
Average target price
6,090 JPY
Spread / Average Target
+2.75%
Consensus
  1. Stock
  2. Equities
  3. Stock Chugai Pharmaceutical Co., Ltd - Japan Exchange